Cargando…
Physical Therapies for Psychosomatic Symptoms and Quality of Life Induced by Aromatase Inhibitors in Breast Cancer Patients: A Systematic Review and Meta-Analysis
OBJECTIVE: To evaluate the effects of Physical Therapies (PTs) on improvement in psychosomatic symptoms and quality of life (QOL) in breast cancer patients. DATA SOURCES: Seven databases (MEDLINE, EMBASE, Cochrane CENTRAL, China National Knowledge Infrastructure, Wangfang, VIP, and China Biology Med...
Autores principales: | Zhu, Xue-Ying, Li, Zhong, Chen, Cong, Feng, Ru-Li, Cheng, Bai-Ru, Liu, Ruo-Yi, Wang, Rui-Ting, Xu, Li, Wang, Yue, Tao, Xin, Zhao, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632958/ https://www.ncbi.nlm.nih.gov/pubmed/34868943 http://dx.doi.org/10.3389/fonc.2021.745280 |
Ejemplares similares
-
Baduanjin’s impact on quality of life and sleep quality in breast cancer survivors receiving aromatase inhibitor therapy: a randomized controlled trial
por: Liao, Jingwen, et al.
Publicado: (2022) -
Childhood physical abuse in outpatients with psychosomatic symptoms
por: Handa, Masanori, et al.
Publicado: (2008) -
Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer
por: Huifang, Li, et al.
Publicado: (2022) -
Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss
por: Chu, Meiling, et al.
Publicado: (2023) -
A Polymorphism at the 3′-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma
por: Liu, Lei, et al.
Publicado: (2013)